Trial Profile
Clinical Trials Insight: 700015678
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2006
Price :
$35
*
At a glance
- Drugs Adecatumumab (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 06 Oct 2006 New trial record.